|
Journal of Histochemistry and Cytochemistry, Vol. 48, 1357-1368, October 2000, Copyright © 2000, The Histochemical Society, Inc.
Expression of the Type I Diabetes-associated Gene LRP5 in Macrophages, Vitamin A System Cells, and the Islets of Langerhans Suggests Multiple Potential Roles in Diabetes
David J. Figueroaa,
J. Fred Hessa,
Bonnie Kya,
Sheryl D. Browna,
Volker Sandigb,
Anne HermanowskiVosatkac,
Rebecca C. J. Twellsd,
John A. Toddd, and
Christopher P. Austina
a Department of Pharmacology, Merck Research Laboratories, West Point, Pennsylvania
b Department of Virus and Cell Biology, Merck Research Laboratories, West Point, Pennsylvania
c Department of Endocrinology, Merck Research Laboratories, Rahway, New Jersey
d Wellcome Trust Centre for the Study of Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, Cambridge, United Kingdom
Correspondence to:
Christopher P. Austin, Dept. of Pharmacology, Merck Research Laboratories, WP26A-3000, PO Box 4, Sumneytown Pike, West Point, PA 19486. E-mail: christopher_austin@merck.com
LRP5 is a novel member of the low-density lipoprotein receptor family that is genetically associated with Type 1 diabetes. As a start to defining the normal function of LRP5 and to generate testable hypotheses of its potential role in Type 1 diabetes pathogenesis, we carried out an extensive expression analysis of this gene at the mRNA and protein levels in normal human, monkey, and mouse, as well as in non-obese diabetic (NOD) mice at several stages of diabetes development. In all species, expression of LRP5 was found in four functionally important cell types: the distributed mononuclear phagocyte system, the islets of Langerhans, vitamin A-metabolizing cells, and CNS neurons. Given the critical role of macrophages in the onset and progression of islet cell destruction in Type 1 diabetes and the hypothesized role of retinoids as modifiers of diabetes progression, these findings suggest that LRP5 may confer Type 1 diabetes risk by altering the normal functioning of one or more of these regulatory systems. Specifically, given that the LRP5 polymorphisms associated with diabetes are in the promoter region of the gene, alterations in LRP5 expression may be responsible for diabetes susceptibility and therefore may be potential targets for therapeutic intervention. (J Histochem Cytochem 48:13571368, 2000)
Key Words:
Type I diabetes, low-density lipoprotein, LRP5, NOD mice, macrophages, retinoids

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y.-f. Guo, D.-h. Xiong, H. Shen, L.-j. Zhao, P. Xiao, Y. Guo, W. Wang, T.-l. Yang, R. R Recker, and H.-w. Deng
Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study
J. Med. Genet.,
October 1, 2006;
43(10):
798 - 803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, N. Adhikari, Q. Li, and J. L. Hall
LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells
Am J Physiol Heart Circ Physiol,
December 1, 2004;
287(6):
H2376 - H2383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yan, D. J. Figueroa, C. P. Austin, Y. Liu, R. M. Bugianesi, R. S. Slaughter, G. J. Kaczorowski, and M. G. Kohler
Expression of Voltage-Gated Potassium Channels in Human and Rhesus Pancreatic Islets
Diabetes,
March 1, 2004;
53(3):
597 - 607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fujino, H. Asaba, M.-J. Kang, Y. Ikeda, H. Sone, S. Takada, D.-H. Kim, R. X. Ioka, M. Ono, H. Tomoyori, et al.
Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion
PNAS,
January 7, 2003;
100(1):
229 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Tulachan, R. Doi, Y. Kawaguchi, S. Tsuji, S. Nakajima, T. Masui, M. Koizumi, E. Toyoda, T. Mori, D. Ito, et al.
All-Trans Retinoic Acid Induces Differentiation of Ducts and Endocrine Cells by Mesenchymal/Epithelial Interactions in Embryonic Pancreas
Diabetes,
January 1, 2003;
52(1):
76 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. T. Van der Ploeg, W. J. Martin, A. D. Howard, R. P. Nargund, C. P. Austin, X. Guan, J. Drisko, D. Cashen, I. Sebhat, A. A. Patchett, et al.
A role for the melanocortin 4 receptor in sexual function
PNAS,
August 20, 2002;
99(17):
11381 - 11386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kato, M. S. Patel, R. Levasseur, I. Lobov, B. H.-J. Chang, D. A. Glass II, C. Hartmann, L. Li, T.-H. Hwang, C. F. Brayton, et al.
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
J. Cell Biol.,
April 15, 2002;
157(2):
303 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kato, M. S. Patel, R. Levasseur, I. Lobov, B. H.-J. Chang, D. A. Glass II, C. Hartmann, L. Li, T.-H. Hwang, C. F. Brayton, et al.
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
J. Cell Biol.,
April 15, 2002;
157(2):
303 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 2000
|
|
|